For other agents ( e.g. , minocycline ) , most guidelines ( 3 / 5 = 0.60 ) recommended neither for nor against , one ( 1 / 5 = 0.20 ) recommended against naloxone ( evidence-based ) and nimodipine ( evidence-based ) , and one ( 1 / 5 = 0.20 ) recommended for neural growth factor ( consensus-based ) .